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INTRODUCTION  
 
The Hayflick limit of primary mouse embryo fibroblasts 
(MEF) is variable since the growth conditions can either 
reduce or extend it [1-3]. We have reported that primary 
MEF expanded every three days (6T3 protocol) 
underwent four population cell doubling and thereafter 
cell proliferation was fully abolished and SA-ȕ-gal+ 
cells induced [4]. However it is known that MEF 
senescence can be induced prematurely, before the end 
of the physiological lifespan, by cellular stresses such as 
the over expression [5] or down regulation [6] of single 
oncogenes and DNA damaging drugs [7-9]. Recently, it 
has been reported that miRNAs are involved in 
senescence of MEF as well as of human diploid 
fibroblasts [10, 11].  
 
An unsolved question is which cells are able to     
escape the in vitro lifespan limit. So far, the molecular 
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characterization of immortalized MEF cell lines has 
shown that functional silencing of either the 
INK4a/ARF  locus [12] or p53 [13] appears necessary to 
bypass senescence. A recurrent concept is that 
mutational events occurring in culture have a key role. 
If mutations confer a proliferative advantage, mutated 
cells can bypass the in vitro lifespan limit and rapidly 
replace the existing population [14, 15]. According to 
this view, the time spent in culture should affect 
immortalization. We modified the 6T3 expansion 
protocol of primary MEF [4] by lengthening the interval 
between passages (15 days versus 3 days) and 
reiterating it until MEF became immortal. Here we 
report that: i) the life span was extended up to 8 
population cell doubling and immortalization was 
consequentially delayed; ii) p21 down regulation marks 
the switch from primary to immortalized MEF;           
iii) deregulation of genes and miRNAs which control 
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Abstract: The life span (Hayflick limit) of primary mouse embryo fibroblasts (M E F) in culture is variable but it is still 
unclear if the escape of the Hayflick limit is also variable. To address this point M E F were expanded every fifteen days 
(6T15) instead of every three days (6T3) until they became immor tal. With this protocol M E F lifespan was extended and 
immortalization accordingly delayed. By testing a panel of genes (p19A R F , p16, p21) and miRN As (miR -20a, miR-21, 
miR-28, miR-290) related to primary M E F senescence, a switch of p21 from up to down regulation, the down regulation 
of specific miRN As as well as a massive shift from diploidy to hyperdiploidy were observed in coincidence with the 
resumption of cell proliferation. Collectively, these data indicate that the inactivation of genes and miRN As, important 
in controlling cell proliferation, might be determinant for the escape from the Hayflick limit. In support of this 
hypothesis was the finding that some of the down regulated miRN As transfected in immortalized M E F inhibited cell 
proliferation thus displaying a tumor suppressor-like activity. 
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cell proliferation pathways correlate with the 
immortalization process; iv) down regulated miRNAs 
can behave as tumor suppressors. 
 
RESULTS  
 
1. The pro senescence axis p53/p21 is disrupted in 
immortalized M E F . 
 
To investigate the relative importance of the time in 
culture versus the number of population cell doubling in 
the MEF immortalization process we modified the split 
time. MEF p0 (passage 0) were thawed, and expanded 
to obtain MEF p1. Thereafter MEF p1 were collected, 
diluted at the appropriate concentration (6x105) and 
grown for 15 days with a medium change every three 
days (6T15 protocol), before the next trypsinization and 
expansion. The 6T15 protocol was reiterated 10 times 
for a total of 150 days in culture. During the first three 
passages a reduced number of population cell doubling 
was observed; afterwards a population of proliferating 
MEF emerged, which rapidly increased (p5) and 
replaced the preexisting cell population (p10) (Fig. 1A). 
At the molecular level we found that both p19ARF and 
p16 were progressively up regulated during passages 
(with respect to the spontaneous level of MEF p0) (Fig. 
1B). Vice versa the expression of p21 was biphasic: 
while it was up regulated till p3 it decreased thereafter 
with a clear switch toward under expression at p6 (Fig. 
1B,C). As p21 is under the direct control of p53, a 
disruption of the p53/p21 axis can be hypothesized at 
the basis of immortalization. 
 
2. Genome stability and miRN A signatures are 
modified in immortalized M E F . 
 
The down regulation of p21 strongly suggests a loss of 
p53 activity. In accordance with the hypothesis, FACS 
analysis showed that while the DNA content 
distribution curve per cell of MEF p1 and MEF p5 were 
very similar and typical of diploid cells (Fig. 2A) a 
massive shift toward cells with higher DNA contents 
was observed in MEF p6 (Fig. 2B). Hyperdiploid cells, 
which emerged from diploid primary MEF, are 
indicative that genomic stability, controlled by p53 [16-
18], is lost. It is of note that a stable hyperdiploid cell 
population is selected within four passages (p6-p10) 
(Fig. 2C). To strengthen the hypothesis of a functional 
loss of p53, in parallel we determined the expression 
profiles of p53 and of miR-34a directly controlled by 
p53. We found that p53 mRNA (Fig. 2D) and protein 
levels did not significantly change up to p6 (Fig. 2E); 
conversely miR-34a appears to increase till p4, starts to 
decrease at p5 to become markedly down regulated at 
p6 (Fig. 2D) reinforcing the idea that p53 becomes non-
functional. 
 
 
 
 
 
 
 
 
 
 
3. The senescence related miRN As are down 
regulated in immortalized M E F . 
 
As the p53/p21 axis of primary MEF was disrupted in 
immortalized MEF, we investigated whether the time 
course of the signatures of miRNAs related to either 
premature (miR-20a [19]) or replicative (miR-21, miR-
28 [20], miR-290 [4]) primary MEF senescence were 
also modified. The analysis showed that while miR-20a 
and miR-290 were down regulated till p6 (Fig 3A) miR-
21 and miR-28 were up regulated. It is worth noting that 
the up regulation of miR-21 and miR-28 is in agreement 
with findings in MEF replicative senescence, while 
miR-290 down regulation is the opposite of previous 
observations because we have shown that miR-290 
steadily increased when either spontaneous or 
nocodazole-induced MEF G1 blocked tetraploid cells 
were present [4]. For that, we examined the cell cycle of 
p1-p5 MEF. We found that under 6T15 protocol no 
significant accumulation of G2/M cells was observed 
(Fig. 3B) suggesting that the failed accumulation of 
G2/M cells was responsible for the lack of miR-290 up 
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Figure   1.   Characterization   of   MEF   under   6T15   propagation  
regimen.   (A)   Proliferation   curve   of   MEF   expressed   as   cell  
doublings   per   passage.   (B)   Quantification   of   p19ARF,   p16   and  
p21   transcripts  per  passage   (each  point   represent  one  passage)  
normalized  to  that  of  MEF  at  passage  0.  (C)  p21  protein  level  at  
the   various   passages.   The   value   reported   under   each   lane  
represents  the  average  of  two  independent  experiments.  
regulation. The miRNA signatures changed markedly 
after p6: while miR-20a and miR-290 remain down 
regulated, although to a lesser extent, miR-21 and miR-
28 switched from up to down regulation (Fig. 3A). 
These data suggest that the deregulation of these two 
senescence related miRNAs, besides miR-34a, is 
involved in MEF immortalization. 
 
 
 
 
 
 
 
 
 
 
4. The transfection of the down regulated miRN As 
reduces the proliferation of immortalized M E F . 
 
To investigate if the deregulated miRNAs play an active 
role in the immortalization, immortalized MEF (p10) 
were transfected with miR-21, miR-28 and miR-34. In 
addition we tested miR-20a and miR-290 whose 
expression was not affected by the immortalization. The 
proliferation data showed that miR-20a and miR-290 
did not affect cell proliferation as expected, the down 
regulated miR-28 and miR-34 significantly reduced the 
proliferation of immortalized MEF with similar 
efficiency, while miR-21 did not inhibit cell 
proliferation (Fig. 3C). These data indicate that the re-
expression of miR-34a and miR-28 (and consequently 
of their controlled pathways) was sufficient to reduce 
the proliferative rate of immortalized MEF and suggest 
that miR-28, like the tumor suppressor miR-34a, could 
have a tumor suppressor activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. M iR-28 behaves as tumor suppressor miRN A . 
 
It is well known that miR-34a has a widespread tumor 
suppressor activity [21, 22]. We show that it behaved as 
such in immortalized MEF as its re-expression inhibits 
cell proliferation, probably by partially restoring the p53 
pathway. Interestingly miR-28, as far as we know, is not 
directly linked to the p53 controlled pathways. We have 
previously reported that in primary MEF miR-28 targets 
the proto-oncogenic splicing factor ASF/SF2 and that in 
turn miR-28 over-expression induces both apoptosis and 
senescence of primary MEF via ASF/SF2 down 
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Figure   2.   MEF   immortalization   is   characterized   by   a   p53-­‐
dependent   events.   DNA   content   profile   per   cell   at   p1/p5   (A),  
p5/p6   (B)   and  p6/p10   (C).   (D)   Fold   change  of  miR-­‐34a  and  p53  
transcripts   at   various   passages   normalized   to   that   of   MEF   at  
passage   0.   (E)   p53   protein   level   at   the   various   passages.   The  
value   reported   under   each   lane   represents   the   average   of   two  
independent  experiments.  
  
Figure   3.   The   re-­‐expression   of   miRNAs   down   regulated   in  
immortalized  MEF  reduces  cell  proliferation.   (A)  Quantification  
of  miR-­‐20a,  miR-­‐21,  miR-­‐28,  miR-­‐290   and  miR-­‐34a   per   passage  
normalized   to   that   of  MEF   at   passage   0.   Dashed   lines   indicate  
the   transition   from   passage   5   to   6.   (B)   Cell   cycle   phase  
distribution   (%)   of   MEF   from   p1   to   p5.   (C)   Population   cell  
doubling  of  immortalized  MEF  after  transfection  of  miR-­‐NC,  miR-­‐
20a,  miR-­‐21,  miR-­‐28,  miR-­‐290  and  miR-­‐34a.  Each  bar  represents  
the   mean   ±   SD   of   three   biological   replicates   (*=p<0.05).   (D)  
Expression   of   ASF/SF2   protein   in   primary   (p3   and   p5)   and  
immortalized   (p10)   MEF.   The   value   reported   under   each   lane  
represents   the   average   of   two   independent   experiments.   (E)  
Expression   of   ASF/SF2   after   the   transfection   of   immortalized  
MEF  with   either  miR-­‐NC   or  miR-­‐28   .   The   value   reported   under  
each   lane   represents   the   average   of   two   independent  
experiments.  
  
regulation [20]. This prompted us to verify the 
expression of ASF/SF2 in primary and immortalized 
MEF. As expected the expression of ASF/SF2 was 
higher in immortalized than in primary MEF (Fig. 3D) 
suggesting a possible post transcriptional control of 
miR-28 on ASF/SF2 expression. To confirm the 
hypothesis, we transfected immortalized MEF (p10) 
with miR-28 and found 50% reduction of ASF/SF2 
expression (Fig. 3E), suggesting that miR-28 control 
cell proliferation by targeting ASF/SF2. These results 
strengthen the idea that miR-28 has a tumor suppressor-
like activity and might be suitable to be tested in tumor 
cell lines defective in miR-28 content. 
 
DISC USSI O N 
 
The in vitro life span defines the number of population 
cell doubling which primary cells can undergo in 
culture. We have reported that MEF under the 6T3 
expansion regimen were able to undergo four 
population cell doubling before achieving senescence . 
In this work we reported that by modifying the 
propagation regimen and growth conditions (6T15 
protocol) MEF slowed down without reaching a 
complete cell proliferation block and restarted 
proliferation after about eight population cell doubling 
(passage 3). These results suggest that activation of p53 
with the consequent induction of p21 in this case may 
favor proliferation arrest rather than senescence as 
previously described [23]. Interestingly the in vitro life 
span of MEF was extended both in terms of  population 
cell doubling and in terms of days in culture, in keeping 
with the hypothesis that p53 activation, by inducing 
quiescence rather than senescence may increase the cell 
life span [24]. The immortalization process is delayed 
accordingly, suggesting that it does not strictly depend 
on the number of cell doubling or the time that the cells 
spend in culture (45 culture days in this case).  
 
The spontaneous immortalization of primary MEF has 
been attributed to either the inactivation of p53 or the 
loss of the INK4a/ARF  locus (p19ARF, p16) [25], two 
loci strictly related to cell proliferation. In this work we 
found that both loci were transcribed and translated 
during passages whereas p21 shifted from up to down 
regulation after p5. As p21 expression is mostly p53 
dependent we argued that despite p53 continued to be 
expressed, it may not be functional any more. In support 
of this conclusion are the down regulation of the p53 
dependent miR-34a and the loss of genomic stability 
revealed by the massive appearance of hyperdiploid 
cells [16-18] 
 
A recurrent concept is that immortalization is due to 
mutations induced by DNA damage occurring during 
the population expansion [14]. The loss of p53 activity 
found in immortalized MEF could be due to either point 
mutation or loss of one allele which appears to be 
sufficient to alter cell growth [15]. In any case the sharp 
increase of cell proliferation suggests that the 
immortalization process is caused by the concomitant 
alteration of multiple pathways. We found that the 
expression of miR-20a, miR-21, miR-28 and miR-290, 
all involved in MEF senescence, were deregulated in 
coincidence with p21 down regulation and increase of 
cell proliferation. As a high number of genes are 
potentially targeted by one miRNA [26], we argued that 
the deregulation of these miRNAs could be in part 
responsible for the absence of cell proliferation control 
characteristic of immortal cells. In particular we 
demonstrate that by replacing miR-28 and miR-34a, 
under expressed in immortalized MEF, cell proliferation 
was reduced suggesting that both miRNAs are 
implicated in immortalization. Evidence in support of 
an anti proliferative role of miR-28 is already available. 
We have shown in primary MEF that miR-28 targets the 
proto-oncogene ASF/SF2, a splicing factor involved in 
the alternative splicing of many transcripts [27, 28] and 
its over expression induces apoptosis and senescence by 
down regulating ASF/SF2 [20]. Our results demonstrate 
that also in immortalized MEF miR-28 targets ASF/SF2 
suggesting that its tumor suppressor activity is due to 
ASF/SF2 inhibition, although other targets cannot be 
excluded. 
 
The fact that the replacement of miR-28 in 
immortalized MEF reduced cell proliferation to the 
same extent as miR-34a further strengthens the 
hypothesis that miR-28 represents a novel TS miRNA. 
MiR-34a is a well known TS miRNA able to inhibit cell 
proliferation of a wide range of tumor cells [21, 29-31] 
as well as of human fibroblasts which extend their 
replicative capacity when treated with miR-34a 
antisense [32]. Conversely miR-290 and miR-20a 
involved in culture and stress induced senescence of 
primary MEF were not able to inhibit proliferation of 
immortal MEF in keeping with the idea that miRNAs 
behave differently in different cellular context [33]. In 
conclusion the delayed immortalization obtained with 
this protocol implies that point mutations; due to DNA 
damage accumulated during population expansion [14], 
are not the only molecular events at the basis of 
immortalization. The most notable feature which marks 
the immortalization process is the drastic p21 down 
regulation possibly due to p53 functional inactivation. 
Associated to the sudden down regulation of p21 was 
the induction of hyperploidy, suggesting that genomic 
instability and/or epigenetic changes are also 
responsible for the immortalization process. 
Interestingly, the switch of p21 expression was 
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accompanied by the change of the signature of miRNAs 
related to MEF senescence, including the p53-
dependent miR-34 and miR-28 [20]. In particular, the 
down regulated miR-28, behaved as a TS miRNA, when 
transfected in immortalized MEF, analogously to the 
well known TS miR-34a, indicating that the comparison 
of the miRNA signature of primary versus immortalized 
cells could allow the identification of novel miRNAs 
with potential tumor suppressor-like activity. 
 
M A T E RI A LS A ND M E T H O DS 
 
Reagents. miRNeasy mini kit, QuantiTect Reverse 
Trascription Kit, miScript Reverse Transcription Kit, 
miScript SYBR Green PCR Kit (QIAGEN, Milano, 
,WDO\ 'XOEHFFR¶V 0RGLILHG (DJOH 0HGLXP-High 
Glucose (D-MEM-HG), foetal bovine serum (FBS) 
(Invitrogen, CA, USA); LightCycler 480 Probes Master, 
Universal ProbeLibrary LNA Probes; LightCycler 480 
SYBR Green I Master (Roche Diagnostic, Mannheim, 
Germany); X-Gal (5-bromo-4-chloro-3-indolylb-D-
galactoside); propidium iodide, anti-Į-tubulin (Sigma-
Aldrich Corporation, Missouri, USA); anti-p21 (Santa 
Cruz Biotechnology, Inc.); ECL, Hybond-C extra 
membranes (Amersham); anti-p53 (Cell Signaling 
Technology). The anti-ASF/SF2 was a gift of Dr. 
Adrian Krainer. MiR-20a, miR-21, miR-28, miR-34, 
miR-290 and miR-NC (negative control) (GenePharma 
Shanghai, China) 
 
Cells and culture conditions. MEF were isolated from 
13.5d mouse embryos, expanded and then replated 
every three days (6T3 protocol). For 6T15 protocol 
MEF p1 were collected, diluted at the appropriate 
concentration (6x105) and grown for 15 days with a 
medium change every three days, before the next 
trypsinization and expansion. MEF were grown in 
'XOEHFFR¶V 0RGLILHG (DJOH 0HGLXP-high glucose 
(DMEM-HG)-10% FBS at 37°C in a humidified 
atmosphere containing 6% CO2. 
 
Cell proliferation. Cell proliferation was measured as 
number of population cell doubling per passage (CD= 
ln(Nf/Ni)/ln2) where Nf is the final number of collected 
cells (day 3) and Ni the initial number of seeded cells 
(day 0).  
 
MiRNAs transfection. Immortalized MEF (p10) were 
seeded at cell density of 1.0x105 per 30 mm diameter 
dish. After 24 hours cells were transfected with either 
miRNAs under test or a double-stranded 
oligonucleotide, named miR-NC. Briefly, 15 ȝl 
Optimem and 25 ȝl transfection buffer plus 80 nM 
miRNA were mixed with a solution of Gene Silencer (5 
ȝl) plus Optimem (25 ȝl). After 15 minutes incubation, 
Optimem was added up to 800 ȝl. After 6 hours the 
medium was replaced with complete DMEM. 
 
Quantification of miRNAs and genes with Q-Real-time 
PCR. Total RNA was extracted from 1x106 cells using 
the miRNeasy mini kit (Qiagen) following the 
PDQXIDFWXUHU¶VUHFommendations. To quantify p19ARF, 
p16 and p21 transcripts, 1µg of total RNA was reverse 
transcribed using QuantiTect Reverse Trascription Kit 
(Qiagen). Real-time PCR (qRT-PCR) was carried out 
with LightCycler 480 (Roche) using LightCycler 480 
SYBER Green I Master (Roche). Mature miR-20a, 
miR-21, miR-28, miR-34a and miR-290 were quantified 
using the miScript System: 1µg of total RNA was 
retrotranscribed with miScript Reverse Transcription 
Kit (Qiagen) and qRT-PCR was carried out using 
miScript SYBR Green PCR Kit (Qiagen). All reactions 
were performed in triplicate. Relative quantification of 
gene expression was calculated with the fit point 
method. Transcript values were normalized with those 
obtained from the amplification of the internal controls 
(GAPDH for transcripts and U6 for miRNAs). The 
following oligonucleotides were used: p19ARF, 
forward (F) (5'-CATGGGTCGCAGGTTCTTG-¶ DQG
reverse (R) (5'-GCTCGCTGTCCTGG GTCTC-3'); p16, 
F (5'-CGACGGGCATAGCTTCAG-3') and R (5'-
GCTCTGCTCTTGGGATTGG-3'); p21, F (5'-
TCCACAGCGATATCCAGACA-3') and R (5'-
GGACATCACCAGGATTGGAC-3'); p53, F (5'-
ATGCCCATGCTACAGAGGAG-3') and R (5'-
AGACTGGCCCTTCTTGGTCT-3'); GAPDH, F (5'-
GCCTTCCGTGTTCCTACCC-3'), R (5'-
TGCCTGCTTCACCACCTTC-3'); miR-20a, F (5'-
TAAAGTGCTTATAGTGCAGGTAG-3'); miR-21, F 
(5'-TAGCTTATCAGACTGATGTTGA-3'), miR-28, F 
(5'-AAGGAGCTCACAGTCTATTGAG-3'); miR-34a, 
F (5'-TGGCAGTGT CTTAGCTGGTTGT-3'); miR-
290, F (5'-gctaatcttctctgtatcgttccaa-3'); U6, F (5'-
CGCAAGGATGACACGCAAATTC-3'). 
 
Western Blot analysis. Equivalent amounts of proteins 
were resolved on 10% SDS-PAGE gels and transferred 
to Hybond-C extra membranes by electro blotting. The 
resulting blots were blocked with 5% nonfat dry milk 
solution. Anti-Į-tubulin (1:1000), anti-p53 (1:500), anti-
p21 (1:1000), anti-ASF/SF2 (1:2000) were used. 
Incubation was performed overnight at 4°C and bands 
were revealed after incubation with the recommended 
secondary antibody coupled to peroxidase using ECL. 
Scanned images were quantified using scion Image 
software and normalized to Į-tubulin. 
 
Cell cycle. Samples of 5x105 of cells under test were 
fixed with 95% ethanol, stained with 50 µg/ml 
propidium iodide (PI), incubated over night at 4°C and 
    
www.impactaging.com                                      5                                                                                        AGING,  July  2011,  Vol.3  No.7  
cell cycle analyzed using a FACScalibur 
cytofluorimeter. The Kolmogorov-Smirnov Statistic 
was used to represent the DNA content profile of MEF 
at the various passages. 
 
Statistical analysis. Data were analyzed using GraphPad 
Prism (GraphPad Sofware, Inc., San Diego, CA). 
Comparisons were evaluated by unpaired t-test. A value 
of p<0.05 (*) was considered statistically significant. 
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